PETV Company Profile and Key Details

PetVivo Holdings, Inc. earnings surprise history is a mixed track record. The quarter that ended June 28, 2024, missed forecasts by -26.32%. The prior quarter beat by -36.84%. Over the last six quarters, Apple has recorded several small beats. These include 62.5% in November 15, 2021.

PETV has shown mixed momentum, gaining 11.11% over the past week and -26.61% over the past quarter, though year-to-date performance is down -24.53%. Short-term trend indicators are bullishly aligned (SMA20 -0.9%, SMA50 -18.49%, SMA200 -42.32%). The stock’s 14-day RSI is 45.89 (neutral), while the ATR of 0.11 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -72.41% below its high and over 142.42% above its low. Average 10-day trading volume of 13.86 thousand shares is slightly above the 3-month average of 9.48 thousand, indicating heightened recent market interest.

PetVivo Holdings, Inc. has 27.90 million shares outstanding. The public float is 21.57 million shares, elevated short interest at 1.00% of float. This equals 129.10 thousand shares. The short ratio is 4.45 days. Institutional investors hold 0.0% of the float. Insiders own 51.2%. Lai John holds 1.29 million shares, Rudelius Robert James has 208.61 thousand shares and A.L. Sarroff Fund, LLC has 187.50 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

PetVivo Holdings, Inc. (OTC:PETV) closed at $0.85 USD, gaining $0.02 (2.41%) from the previous close of $0.83. The stock is currently mid-range between its 52-week high and low $0.60 and $1.69. With a market capitalization of about $23.05 million, PetVivo Holdings, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.26). Key stats such as the average daily volume over the past year has been around 8.51 thousand shares, trading with heavier-than-usual volume. Headquartered in Minneapolis, MN, PetVivo Holdings, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO John Lai, the company employs approximately 20 people and listed since September 08, 2014. PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals.

PetVivo Holdings, Inc. trades at a P/E ratio of -2.16, slightly below the S&P 500 average, with a price-to-sales ratio of 20.83 and a price-to-book ratio of 8.51 trading at moderately above to book value. The P/FCF stands at -3.29, also above market averages.

Our AI price prediction model suggests that PetVivo Holdings, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.35%, with price expected at $0.87 by July 10, 2026, within a range of $0.83 to $0.90 3-Month Outlook: Projected fall of -23.53%, reaching $0.65 by September 24, 2026, with a range of $0.58 to $0.71. 1-Year Outlook: Projected gain of 721.18%, with price at $6.98 by June 25, 2027, within a range of $2.29 to $9.27.

PetVivo Holdings, Inc. (NASDAQ:PETV) shares are down -24.53% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows PetVivo Holdings, Inc. trading at a premium to the broader market with a P/E of -2.16. Our AI forecast model points to short-term strength (2.35% over two weeks), a medium-term fall (-23.53% over three months), and a longer-term gain (721.18% over one year), with expected trading ranges indicating moderate volatility.

PetVivo Holdings, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $2.44. This means the shares are trading below this model’s fair value.